| 0 (0%) | 12-26 21:17 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 333.51 | 1-year : | 389.54 |
| Resists | First : | 285.54 | Second : | 333.51 |
| Pivot price | 271.63 |
|||
| Supports | First : | 265.62 | Second : | 253.32 |
| MAs | MA(5) : | 275.17  |
MA(20) : | 273.25 |
| MA(100) : | 264.25 |
MA(250) : | 0 | |
| MACD | MACD : | 0.4 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 59.2 |
D(3) : | 56.7 |
| RSI | RSI(14): 51.7 |
|||
| 52-week | High : | 348.89 | Low : | 187.42 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ WST ] has closed below upper band by 34.3%. Bollinger Bands are 38.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 277.79 - 279.3 | 279.3 - 280.56 |
| Low: | 269.11 - 271.02 | 271.02 - 272.61 |
| Close: | 271.42 - 274.34 | 274.34 - 276.76 |
Tue, 23 Dec 2025
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Mon, 22 Dec 2025
Riverbridge Partners LLC Cuts Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Mon, 22 Dec 2025
West Pharmaceutical Services, Inc. $WST Position Decreased by Seilern Investment Management Ltd - MarketBeat
Wed, 17 Dec 2025
West Pharmaceutical Services Stock: Is WST Underperforming the Healthcare Sector? - Yahoo Finance
Wed, 17 Dec 2025
West Pharmaceutical Services (WST): Reassessing Valuation After a 20% Share Price Decline - Yahoo Finance
Thu, 04 Dec 2025
West Pharmaceutical Services (WST) Rebounded in Q3 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 72 (M) |
| Shares Float | 71 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 97.7 (%) |
| Shares Short | 2,060 (K) |
| Shares Short P.Month | 1,430 (K) |
| EPS | 6.73 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 42.43 |
| Profit Margin | 16.2 % |
| Operating Margin | 21.8 % |
| Return on Assets (ttm) | 10.2 % |
| Return on Equity (ttm) | 16.9 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 14.87 |
| Sales Per Share | 41.97 |
| EBITDA (p.s.) | 11.13 |
| Qtrly Earnings Growth | 3.7 % |
| Operating Cash Flow | 694 (M) |
| Levered Free Cash Flow | 251 (M) |
| PE Ratio | 40.69 |
| PEG Ratio | 0 |
| Price to Book value | 6.46 |
| Price to Sales | 6.53 |
| Price to Cash Flow | 28.44 |
| Dividend | 0.21 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|